Cargando…
Co-treatment With BGP-15 Exacerbates 5-Fluorouracil-Induced Gastrointestinal Dysfunction
Gastrointestinal (GI) side-effects of chemotherapy present a constant impediment to efficient and tolerable treatment of cancer. GI symptoms often lead to dose reduction, delays and cessation of treatment. Chemotherapy-induced nausea, bloating, vomiting, constipation, and/or diarrhea can persist up...
Autores principales: | McQuade, Rachel M., Al Thaalibi, Maryam, Petersen, Aaron C., Abalo, Raquel, Bornstein, Joel C., Rybalka, Emma, Nurgali, Kulmira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518025/ https://www.ncbi.nlm.nih.gov/pubmed/31139044 http://dx.doi.org/10.3389/fnins.2019.00449 |
Ejemplares similares
-
Irinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons
por: McQuade, Rachel M., et al.
Publicado: (2017) -
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments
por: McQuade, Rachel M., et al.
Publicado: (2016) -
The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction
por: Campelj, Dean G., et al.
Publicado: (2020) -
BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice
por: Sorensen, James C., et al.
Publicado: (2017) -
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
por: Nurgali, Kulmira, et al.
Publicado: (2018)